LMF Acquisition Opportunities Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.0149
- Today's High:
- $0.0149
- Open Price:
- $0.0149
- 52W Low:
- $0.006
- 52W High:
- $0.235
- Prev. Close:
- $0.0149
- Volume:
- 600
Company Statistics
- Market Cap.:
- $0
- Book Value:
- -6.078
- Revenue TTM:
- $0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- $0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
LMF Acquisition Opportunities Inc had its IPO on 2021-03-18 under the ticker symbol ICUCW.
The company operates in the Healthcare sector and Biotechnology industry. LMF Acquisition Opportunities Inc has a staff strength of 3 employees.
Stock update
Shares of LMF Acquisition Opportunities Inc opened at $0.01 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.01 - $0.01, and closed at $0.01.
This is a 0% increase from the previous day's closing price.
A total volume of 600 shares were traded at the close of the day’s session.
In the last one week, shares of LMF Acquisition Opportunities Inc have slipped by -7.45%.
LMF Acquisition Opportunities Inc's Key Ratios
LMF Acquisition Opportunities Inc has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months LMF Acquisition Opportunities Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures LMF Acquisition Opportunities Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, LMF Acquisition Opportunities Inc’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q2, LMF Acquisition Opportunities Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
LMF Acquisition Opportunities Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into LMF Acquisition Opportunities Inc’s profitability.
LMF Acquisition Opportunities Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
LMF Acquisition Opportunities Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $2.33 million
- Total Liabilities
- $13.78 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
LMF Acquisition Opportunities Inc ended 2024 with $2.33 million in total assets and $0 in total liabilities. Its intangible assets were valued at $2.33 million while shareholder equity stood at $-11448000.00.
LMF Acquisition Opportunities Inc ended 2024 with $0 in deferred long-term liabilities, $13.78 million in other current liabilities, in common stock, $-108256000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $13000.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.
LMF Acquisition Opportunities Inc’s total current assets stands at $2.33 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $4.36 million and inventory worth $0.
In 2024, LMF Acquisition Opportunities Inc's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, LMF Acquisition Opportunities Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.01
- 52-Week High
- $0.235
- 52-Week Low
- $0.006
- Analyst Target Price
- $
LMF Acquisition Opportunities Inc stock is currently trading at $0.01 per share. It touched a 52-week high of $0.235 and a 52-week low of $0.235. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.03 and 200-day moving average was $0.07 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About LMF Acquisition Opportunities Inc
Similar Industry Stocks (Biotechnology)
Most Active
Top Gainers
Top Losers
About
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.